Massive pancreatic cancer registry launched to unlock Real-World insights
NCT ID NCT07171515
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is creating a large, detailed registry of people with pancreatic cancer. Researchers will collect information from medical records and follow new patients over time. The goal is to gather real-world data to better understand the disease and its treatment, which could lead to improved care in the future. Over 6,900 participants are expected to take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide valuable insights into pancreatic cancer, helping doctors better understand the disease and potentially improve treatment strategies.
- What could go wrong
- This is an observational registry, not a treatment trial. It will not directly test a new therapy, and the findings may take years to influence patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
National Cancer Center
Goyang, Gyeonggido, 10408, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- MRI might reveal hidden pancreatic risks in obesity
- Can a new PET tracer light up hidden cancers?
- Can a pill rouse the immune system against pancreatic cancer?